Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Kristen Bibeau"'
Autor:
Amit G. Pandya, Theresa Amoloja, Kristen Bibeau, Dana DiBenedetti, Katherine Kosa, Kathleen Butler, Deanna Kornacki, Khaled Ezzedine
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2467-2478 (2024)
Abstract Introduction Vitiligo is an autoimmune disease, causing skin depigmentation. Individuals with vitiligo incur substantial psychosocial burden and have expressed frustration with their treatments. Here, we describe the burden of vitiligo and o
Externí odkaz:
https://doaj.org/article/e0c4e02f3ef94bd68441c506ef311468
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 8, Pp 2223-2234 (2024)
Abstract Introduction This study reports psychometric testing of the facial and total Vitiligo Area Scoring Index quantitative clinical instruments (F-VASI [range: 0–3], T-VASI [range: 0–100], respectively) using data from two phase 3 randomized,
Externí odkaz:
https://doaj.org/article/554db33241714cc880bba2cd66c129d5
Autor:
Ghassan K. Abou-Alfa, Kristen Bibeau, Nikolaus Schultz, Amin Yaqubie, Brittanie Millang, Haobo Ren, Luis Féliz
Publikováno v:
Targeted Oncology. 17:517-527
First-line standard-of-care therapy for advanced cholangiocarcinoma is gemcitabine plus cisplatin; there is no established second-line systemic therapy. Fibroblast growth factor receptor (FGFR)-2 fusions/rearrangements can be oncogenic drivers, occur
Autor:
Fiona Kuo, Kristen Bibeau, Khaled Ezzedine, Daniel Sturm, Heather Jones, Amit G. Pandya, Viktoria Eleftheriadou
Publikováno v:
American Journal of Clinical Dermatology
Background Patients with vitiligo experience reduced quality of life. Objective To comprehensively describe the available evidence for psychosocial burden in vitiligo. Methods A systematic review of observational studies and clinical trials identifie
Autor:
Dawn C. Buse, Paul P. Yeung, Marcelo E. Bigal, Kristen Bibeau, Joshua M. Cohen, Maja Galic, Michael J. Seminerio, Richard B. Lipton, Ernesto Aycardi
Publikováno v:
Headache
Objective To evaluate the efficacy of fremanezumab in patients with chronic migraine (CM) and moderate to severe depression. Background Fremanezumab, a fully humanized monoclonal antibody that selectively targets calcitonin gene–related peptide, ha
Publikováno v:
JCO Precision Oncology.
PURPOSE Oncogenic fibroblast growth factor receptor (FGFR) gene alterations have been described in patients with cholangiocarcinoma (CCA). This post hoc analysis assessed progression-free survival (PFS) in patients who had received first- or second-l
Autor:
Verena Ramirez Campos, Rashmi B. Halker Singh, Michael J. Seminerio, Jessica Ailani, Maja Galic, Joshua M. Cohen, Kristen Bibeau, Richard B. Lipton
Publikováno v:
Headache
BACKGROUND Migraine preventive medications are used to reduce headache frequency, severity, and duration. In patients with chronic migraine (CM), reversion to episodic migraine (EM) is an important treatment goal. OBJECTIVE To evaluate the effect of
Autor:
John E. Harris, Kristen Bibeau, Iltefat H. Hamzavi, Pearl Grimes, Anouk Lindley, Christine LaFiura, Khaled Ezzedine
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB167
Autor:
Kristen Bibeau, John E. Harris, Iltefat H. Hamzavi, Anouk Lindley, Christine LaFiura, Khaled Ezzedine
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB159
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB119